Cosponsor
Sign in

HR 950 · in committee · significant

Saving Seniors Money on Prescriptions Act

What this bill does

  • Pharmacy benefit managers must report detailed prescription drug cost and pricing data to Medicare drug plans.
  • Medicare seniors and prescription drug plan sponsors are affected by increased price transparency requirements.
  • PBMs face civil penalties for non-compliance; the GAO must study how to streamline reporting requirements.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How would requiring pharmacy benefit managers to report detailed pricing data help Medicare beneficiaries make decisions about their prescriptions?

  2. 02

    What compliance costs might pharmacy benefit managers pass along to drug plans or patients, and who would ultimately bear that burden?

  3. 03

    What specific pricing information does the GAO study need to identify before streamlining these new reporting requirements?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · D-OH-1

Greg Landsman

Citizen cosponsors

0

In Congress

2/ 435

House Reps cosponsoring

Introduced 2025-02-04

Joining the bill

Legislative timeline

  1. 2025-02-04 · house · IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  2. 2025-02-04 · house · IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  3. 2025-02-04 · IntroReferral

    Introduced in House

  4. 2025-02-04 · IntroReferral

    Introduced in House

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.